Alx Oncology Holdings (ALXO) Short-term Investments (2022 - 2026)

Alx Oncology Holdings' Short-term Investments history runs 5 years deep, the most recent figure standing at $108.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 39.92% year-over-year to $108.0 million; the TTM figure through Mar 2026 stood at $108.0 million (up 39.92% YoY), while the FY2025 annual figure was $28.4 million, down 74.21% from the prior year.
• Short-term Investments came in at $108.0 million for Q1 2026 at Alx Oncology Holdings, up from $28.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $247.0 million in Q2 2022 to a low of $28.4 million in Q4 2025.
• A 5-year average of $139.2 million and a median of $143.4 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments tumbled 74.21% in 2025 and soared 39.92% in 2026, its largest moves.
• Alx Oncology Holdings' Short-term Investments stood at $217.4 million in 2022, then slipped by 26.25% to $160.3 million in 2023, then slumped by 31.27% to $110.2 million in 2024, then sank by 74.21% to $28.4 million in 2025, then soared by 280.19% to $108.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $108.0 million, $28.4 million, and $37.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison